New Drug Development & Regulatory News
Kateryna Kon Shutterstock
Drug candidate provides hope for treating Parkinson's and MND
Samsara Therapeutics has unveiled a promising autophagy drug candidate, offering new hope for people with Parkinson's and motor neurone disease. Read more
23 May 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
MGC Pharma granted permission to research new medicines with psilocybin
MGC Pharmaceuticals, a European-based pharmaceutical company, has received permission from the Slovenian Ministry of Health to undergo scientific research development on the psychedelic compound psilocybin. Read more
3 Apr 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Clinical trial regulations set to have biggest overhaul in 20 years
A series of new measures will be introduced by the Medicines and Healthcare products Regulatory Agency (MHRA) with support from partners to make it faster and easier to gain approval and to run clinical trials in the UK. Read more
27 Mar 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
New study shows true impact of endotoxins in 3D in vitro models
A new study has found that utilisation of highly purified gelatin biomaterials for 3D in vitro models can significantly enhance the reliability and reproducibility in these models, creating new possibilities for replacing preclinical animal trials. Read more
16 Mar 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
FDA approves Biologics License of lecanemab for treatment of Alzheimer's
The FDA has accepted Eisai's supplemental Biologics License Application (sBLA) for LEQEMBITM (lecanemab-irmb) 100 mg/mL injection for intravenous use, supporting the conversion of the accelerated approval of LEQEMBI to a traditional approval. Read more
6 Mar 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Breakthrough treatment for patients with severe form of childhood epilepsy
UCB’s FINTEPLA (fenfluramine) oral solution has been approved in the EU for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) as an add-on therapy to other anti-epileptic medicines for patients two years of age and older. Read more
10 Feb 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
Manage, optimize, engage: role of content experience platforms in 2023
How to create hyper-personalised experiences with a content experience platform (CXP) Read more
12 May 2023
Life sciences manufacturing projects to receive £277 million investment
Four life sciences companies will see £277 million in joint government and industry backing to help grow and advance their manufacturing projects - another tactic in the Chancellor's growth scheme to grow and harness life sciences innovation. Read more
28 Mar 2023
Pharma Manufacturing News + Pharma Finance and Investment News
Stevanato and Recipharm collaborate to improve soft mist inhalers
A strategic collaboration between Stevanato Group and Recipharm aims to provide innovative primary packaging to pharma and biopharma companies using Recipharm’s proprietary soft mist inhalers. Read more
17 Mar 2023
New study shows true impact of endotoxins in 3D in vitro models
A new study has found that utilisation of highly purified gelatin biomaterials for 3D in vitro models can significantly enhance the reliability and reproducibility in these models, creating new possibilities for replacing preclinical animal trials. Read more
16 Mar 2023
Pharma Manufacturing News + New Drug Development & Regulatory News
MM Packaging Spearheads Anticounterfeiting Discussion at PHARMAP 2023
MM Packaging is at PHARMAP 2023 as they tackle anticounterfeiting measures in the pharmaceutical industry, emphasizing serialisation and their partnership with Crane Micro-optics. Read more
5 Jun 2023
VaxEquity and CPI Secure £700K Innovate UK Grant to Boost RNA Vaccine Development
VaxEquity and CPI receive a £700K grant from Innovate UK, funding a project to enhance RNA vaccine manufacturing and fast-track an influenza vaccine into clinical trials. Read more
5 Jun 2023
MGC Pharma's CannEpil Arrives in the UK: A Leap Forward in Epilepsy Treatment
MGC Pharma's breakthrough in epilepsy treatment with CannEpil is now available in the UK. This high-CBD, low-THC formulation is part of a pioneering approach to refractory epilepsy treatment. Learn how MGC Pharma is transforming patient care a Read more
31 May 2023
Speedata's APU: Transforming Big Data Analytics Across Industries
Discover Speedata's groundbreaking Analytics Processing Unit (APU), designed to accelerate big data analytics across industries. Witness a 280x speed increase in pharmaceutical workloads, revolutionising drug discovery. Speedata's APU: the future of Read more
31 May 2023
Burnout Crisis Looms in Pharma Industry, New O.C. Tanner Study Warns
The 2023 Global Culture Report by O.C. Tanner reveals that a poor work-life balance and a lack of staff recognition are key factors driving physical and emotional distress among pharmaceutical industry employees. Read more
24 May 2023
Touchlight Completes Expansion of UK DNA Manufacturing Facility to Meet Growing Demand in Genetic Medicine
Touchlight, a leader in enzymatic DNA production, has completed the redevelopment and expansion of its UK manufacturing facility, increasing its capacity threefold. Read more
24 May 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
Manage, optimize, engage: role of content experience platforms in 2023
How to create hyper-personalised experiences with a content experience platform (CXP) Read more
12 May 2023
Sponsored Content
Optimization of a bio-decontamination process: atomized hydrogen peroxide new cycle development method
Risk-based cycle development, considering not only the required decontamination level but the type of load and cycle total time Read more
3 Feb 2023
11:15
